Euronext NV (XAMS:ENX) Research & Development: €0.00 Mil (TTM As of Mar. 2026)


What is Euronext NV Research & Development?

Euronext NV XAMS:ENX 92 Research & Development is €0.00 Mil as of Mar. 2026. GuruFocus rates XAMS:ENX with a GF Score™ of 92/100. The stock has 4 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Euronext NV's Research & Development for the three months ended in Mar. 2026 was €0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was €0.00 Mil.

Euronext NV  (XAMS:ENX) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Euronext NV Research & Development Related Terms

Euronext NV Research & Development Historical Data

* Premium members only.

The historical data trend for Euronext NV's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Euronext NV Research & Development Chart

Euronext NV Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Euronext NV Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Euronext NV Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0.00 Mil mean?
Euronext NV (XAMS:ENX) has a Research & Development of €0.00 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Euronext NV and its competitors.
Is Euronext NV's Research & Development too high?
Euronext NV's current Research & Development is €0.00 Mil. Overall, Euronext NV has a GF Score™ of 92/100, reflecting its overall financial health beyond just this single metric.
How does Euronext NV's Research & Development compare to SPGI and CME?
Euronext NV's Research & Development of €0.00 Mil can be compared against companies in the Capital Markets industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Capital Markets company?
A good Research & Development depends on the Capital Markets industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Euronext NV and its competitors. Euronext NV's current Research & Development is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Euronext NV stock overvalued right now?
Euronext NV (XAMS:ENX) has a current Research & Development of €0.00 Mil. The current Research & Development is €0.00 Mil. Euronext NV's overall GF Score™ is 92/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Euronext NV (XAMS:ENX), the current Research & Development is €0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Euronext NV Business Description

Address Beursplein 5, Amsterdam, NLD, 1012 JW
Euronext is a financial exchange group with trading venues in Amsterdam, Brussels, Dublin, Lisbon, Milan, Oslo, and Paris, covering primarily cash equities, fixed income, and index and single stock derivatives. With the acquisition of Borsa Italiana, Euronext has also taken control of CC&G, the Italian multi-asset clearing house, as well as Monte Titoli, the Italian central securities depository. This complements Euronext's other CSDs in Norway, Denmark and Portugal. Euronext is the owner of the CAC40, AEX, BEL 20, ISEQ 20, OBX, and PSI 20 indexes.